Stocksigma LogoStocksigma Logo

Genomic Valley Biotech Reports Q2 FY27 Loss on Zero Revenue

Genomic Valley Biotech reported zero revenue from operations for Q2 ended 30th Sep'26, down from ₹3.80 lakh in Q1 ended 30th Jun'26 and ₹9.00 lakh in Q2

Genomic Valley Biotech Reports Q2 FY27 Loss on Zero Revenue

Genomic Valley Biotech Ltd · Financial Result · 30 Oct 2026, 11:43 pm

Genomic Valley Biotech Reports Q2 FY27 Loss on Zero Revenue Genomic Valley Biotech reported zero revenue from operations for Q2 ended 30th Sep'26, down from ₹3.80 lakh in Q1 ended 30th Jun'26 and ₹9.00 lakh in Q2 ended 30th Sep'25. Total expenses stood at ₹1.98 lakh versus ₹2.34 lakh QoQ and ₹8.67 lakh YoY. Consequently, the company posted a net loss of ₹1.98 lakh compared to a net profit of ₹1.46 lakh QoQ and ₹0.33 lakh YoY, resulting in basic and diluted EPS of -₹0.06. H1 net loss stood at ₹0.52 lakh.

Original exchange filing (PDF)

More announcements from Genomic Valley Biotech Ltd

All Genomic Valley Biotech Ltd announcements